Insider Transactions in Q3 2021 at Epizyme, Inc. (EPZM)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,930
+10.85%
|
$14,650
$5.12 P/Share
|
|
Sep 30
2021
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+2.67%
|
$23,200
$5.12 P/Share
|
|
Aug 16
2021
|
Shefali Agarwal |
BUY
Grant, award, or other acquisition
|
Direct |
59,166
+26.57%
|
-
|
|
Aug 16
2021
|
Grant C. Bogle President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+47.8%
|
-
|
|
Aug 16
2021
|
Matthew Ros Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+20.17%
|
-
|
|
Aug 16
2021
|
Joseph Beaulieu Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,833
+34.42%
|
-
|
|
Aug 16
2021
|
Jeffery Kutok Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,832
+31.46%
|
-
|